About Schwarz Pharma
Schwarz Pharma is a Healthcare company based in Monheim (Germany) founded in 1946, and was acquired by UCB in September 2006. Drugs for cardiovascular system, gastrointestinal tract ,asthma, neurology and urology. Schwarz Pharma has completed 1 acquisition, including Aderis Pharma. Its focus areas include Diversified Pharmaceuticals. Its legal entity is SCHWARZ PHARMA LIMITED.
Company details
Schwarz Pharma was a pharmaceutical company focussed on developing drugs for the treatment of diseases related to the cardiovascular system , gastrointestinal tract ,asthma, neurology and urology Its products include generic omeprazole, a proton-pump-inhibitor to treat symptoms of gastroesophageal reflux disease (GERD) and Neupro (rotigotine transdermal patch) for the treatment of early Parkinsons disease. It also had three projects, one for epilepsy, one for neuropathic pain and one for Restless Legs Syndrome in the clinical development. It was acquired by UCB in September 2006 for 5.6B.
- Headquarters Monheim, Germany
- Stage Acquired
- SectorsHealthcare
- Website schwarzpharma.com
- Social LinkedIn
- Acquired by UCB (Sep 2006)
- Legal Name Schwarz Pharma Limited
- Investors
- Investments & Acquisitions
- Acquired byUCB
(Sep 2006)
Investors in Schwarz Pharma
Schwarz Pharma has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include UCB.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Therapies for immunological and neurological disorders are developed. | 1928 | ucb.com | Brussels, Belgium |
Investor details for Schwarz Pharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Schwarz Pharma
Schwarz Pharma has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Aderis Pharma.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Developer of small molecule drug candidates for the central nervous system, cardiovascular, and inflammatory diseases | aderis.com | Hopkinton, United States | 1994 | Jul 2005 | •••• |
Complete acquisition details for Schwarz Pharma
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Schwarz Pharma
3 dated milestones of Schwarz Pharma across 60 years, from founding to its latest funding, stage changes and deals.
- Founded Schwarz Pharma is founded.
- Acquisition Acquires Aderis Pharma.
- Exit Acquired by UCB.
Web traffic of Schwarz Pharma
Websites that share an audience with Schwarz Pharma (schwarzpharma.com).
Websites whose visitors overlap most with Schwarz Pharma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
ucb.de | ucb.de | 100% | #3,475,534 | – | |
shssb.org | shssb.org | 56% | – | ||
westmidlands.nhs.uk | westmidlands.nhs.uk | 56% | – | ||
sthct.nhs.uk | sthct.nhs.uk | 56% | – | ||
leeds.nhs.uk | leeds.nhs.uk | 56% | – | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 22 similar websites and full traffic analytics for Schwarz Pharma
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 22 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Schwarz Pharma
Schwarz Pharma was founded in 1946.
Schwarz Pharma is headquartered in Monheim, Germany. It is registered at Monheim, North Rhine-westphalia, Germany.
Schwarz Pharma was a pharmaceutical company focussed on developing drugs for the treatment of diseases related to the cardiovascular system , gastrointestinal tract ,asthma, neurology and urology Its products include generic omeprazole, a proton-pump-inhibitor to treat symptoms of gastroesophageal reflux disease (GERD) and Neupro (rotigotine transdermal patch) for the treatment of early Parkinsons disease. It also had three projects, one for epilepsy, one for neuropathic pain and one for Restless Legs Syndrome in the clinical development. It was acquired by UCB in September 2006 for 5.6B.
Schwarz Pharma has made 1 acquisition, including Aderis Pharma.
Schwarz Pharma has 1 investor. Key investors include UCB.
Schwarz Pharma operates through Schwarz Pharma Limited.
Yes. Schwarz Pharma was acquired by UCB in September 2006.